Don’t send a generic resume — generate a resume and cover letter tailored to this exact role.
Artia Global Partners LP seeks a Biotech / Biopharma Equity Analyst to focus on therapeutics across market caps and stages. The role, based in Miami with hybrid flexibility, involves rigorous fundamental research and collaboration with the CIO and senior team.
The ideal candidate has 3+ years in healthcare equity research or related fields, plus strong modeling and valuation skills. MD/PhD strongly preferred; excellent communication and integrity are essential.
Artia Global Partners LP is a multidisciplinary, healthcare-focused investment firm. We employ a flexible, fundamentals-driven, and long-term approach to investing. Our team focuses on high-conviction investment opportunities across all global healthcare subsectors. Launched in 2022, Artia Global currently manages more than $600 million in AUM through its flagship long/short equity fund.
We value the relentless pursuit of excellence, independent thinking, intellectual curiosity, an entrepreneurial mindset, integrity, and collaboration.
We are seeking a highly qualified Biotech / Biopharma Equity Analyst to join our growing and entrepreneurial team. The analyst will focus on therapeutics subsectors (biotech and pharmaceuticals), spanning across market capitalizations and development stages. The role is based in our Miami office, with potential hybrid work flexibility.
The analyst will conduct rigorous fundamental research to develop investment theses and identify compelling opportunities — primarily in the public equity space, with selective exposure to early-stage private investments. The analyst will work closely and collaboratively with the CIO (an MD/MBA) and our team of seasoned professionals.
Miami, FL office based, with potential hybrid work flexibility
Highly competitive and commensurate with experience